[moc::"[[MOC Nasopharynx]]"]
>[!title]
> PC 0501 [Lee Cancer '15](https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.29208), ['20](https://pubmed.ncbi.nlm.nih.gov/32497261/): 

>[!intervention] 
> 6 arms: 1) CTX→ CCRT vs. CCRT→ CTX 2) PX vs. PF chemo 3) AFX vs. STD.

# study
- 803 pts. 
	- Stage III-IVB. 
	- Non-keratinizing. 
	- 2006-2012.

- Treatment
	- PX = CDDP + Xeloda; PF = CDDP + 5-FU.

# results
- 5y PFS ichemo: 78%
- 5y PFS achemo: 62%
- 5y OS  ichemo: 84%
- 5y OS  achemo: 72%

>[!summary] 
> 16% 5y PFS, 12% OS advantage with induction over adjuvant therapy
>^summary

![[10_NPC501.pdf]]